Home Wealth  Money Cell Therapeutics Says Panel Confirms Study Robustness

Cell Therapeutics Says Panel Confirms Study Robustness

Posted: Sep. 29th, 2011  |  By Forbes

powered by Forbes

RSS Syndicated News Email a Friend Suggest an Article Share Visit Website

Cell Therapeutics shares are getting a boost today after the company announced that a second independent radiology assessment of data from a clinical trial of the companys antitumor treatment pixantrone confirmed the statistical robustness of the data.

The response and progression endpoint data was previously submitted to the US Food and Drug Administration with the new drug application for pixantrone.

The second assessment was recommended by the FDAs Office of New Drugs as part of Cell Therapeutics (nasdaq: CTIC - news - people ) appeal to the complete response letter it had previously received from the FDA.

The company said it plans on resubmitting the drug as early as next month for accelerated approval, which could provide an FDA action date by April 2012.

Cell Therapeutics had announced earlier in the week that a UnitedHealth Group (nyse: UNH - news - people ) executive, Reed Tuckson, has joined its board.

This year, the company has licensed rights from Chroma Therapeutics to develop tosedostat, and it has an ongoing relationship with Novartis (nyse: NVS - news - people ) for the licensing of Opaxio.

Market News Video produces and distributes online videos about stocks and investing.




Share on Facebook Share
See Next Article
Need to Get Away?
Top 10 Business Hotels
Who says you canít mix business with pleasure?
Read More
More Articles from Forbes.com

advertisement
Quick Links
Autos
Boating
Real Estate
Luxury Travel
Fashion
Search Real Estate
Find Your Dream Home
Search for homes by
State, Country or Style.
Event Calendar
advertisement
Current News & Features
Louis Vuitton Rolls Out Their New Luggage Line
Can China be a Driving Force in the Superyacht Industry?
Top 4 Mountain Restaurants in Val d'Isere
The Rise of Natural Wine
East Coast Defender Taps Into the Heart of the Aftermarket
Nice to Meat You: Penn & Teller Take On Guy Savoy
Gaining Traction With The Porsche 911 Edurance Racing Edition
The Dyson 360 Eye Is Good Clean Fun
Let Your Baggage Be Light With The New TUMI V3
Vertu Shows Off Their Craftsmanship Chops With The New Aster Leaf
See the complete list
 
Featured Photo Gallery
See the complete list
THINGS WE LIKE